| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |